Home › NDC Lookup › Ingredients › Allopurinol › 00591-5543-01
⚪image loading
(from DailyMed)

Allopurinol 100 mg Tablet, 100-count — NDC 0591-5543-01 (Billing 00591-5543-01)

by Actavis Pharma, Inc. · 100 TABLET in 1 BOTTLE, PLASTIC

This is a package of 100 tablets of Allopurinol 100 mg Tablet from Actavis Pharma, Inc., no longer marketed (first marketed Apr 2009), no longer in the FDA NDC Directory; retail pharmacies pay about $0.0317 per tablet (NADAC).

NDC 00591-5543-01
🏷️ FDA NDC (as labeled) 0591-5543-01 billing pads the labeler segment with a zero
This package
Contains100-count Cost per ea$0.0317 NADAC Per package$3.17 / 100 tablets Pack sizes4 compare ↓
Discontinued Non-controlled ⚠ On shortage ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 0591-5543-01 alone.

Record
FDA NDC Directory package listing · Drug for further processing
Code segments
0591 labeler · 5543 product · 01 package
Listing certified through
Dec 31, 2026
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 0591554301 8
FDA record last changed
Oct 8, 2026
⚠️
Active FDA shortage. Allopurinol Tablet is currently reported in shortage by the FDA. Shortage details →
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0591-5543-01
Product NDC 0591-5543
11-digit billing NDC 00591554301
NCPDP billing unit EA — each (per item)
SPL Set ID 531594e1-34a6-49c3-a3ad-7e697af83807
DEA schedule Non-controlled
Marketing category DRUG FOR FURTHER PROCESSING
Marketing status Discontinued
FDA listing status Discontinued by firm
Marketing start 2009-04-06
Dosage form TABLET
Substance ALLOPURINOL

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 68000010000305
GPI class Allopurinol
GCN Seq No 002535
GCN 07070
HICL code 001100
Ingredient (HICL) Allopurinol
HIC1 code C
Therapeutic class — broad (HIC1) Electrolyte Balance/Metabolism/Nutrition
HIC2 code C7
Therapeutic class — intermediate (HIC2) Metabolic Inhibitors And Stimulants
HIC3 code C7A
Therapeutic class — specific (HIC3) Hyperuricemia Tx - Xanthine Oxidase Inhibitors
AHFS code 92:16.00.00
AHFS class Antigout Agents
FDB label name ALLOPURINOL 100 MG TABLET
FDB brand name Allopurinol
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 002535
  • GCN: 07070
  • GPI-14 (Medi-Span): 68000010000305
  • HICL (First Databank): 001100
  • AHFS class code: 92:16.00.00
Why two NDCs? The FDA registers this code as 0591-5543-01 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00591-5543-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name ALLOPURINOL 100 MG TABLET Ingredient Allopurinol
📖 What it is MedlinePlus · NLM

Allopurinol is used to treat gout (a type of arthritis in which uric acid, a naturally occurring substance in the body, builds up in the joints and causes sudden attacks of redness, swelling, pain, and heat in one or more joints). Allopurinol is also used to treat high levels of uric acid that builds up in the blood as tumors break down in people with certain types of cancer who are being treated with chemotherapy medications. It is also used to treat kidney stones that have come back in people who have high levels of uric acid in their urine. Allopurinol is in a class of medications called xa...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Allopurinol lowers uric acid. The tablets are used for gout, for high uric acid caused by cancer treatment, and for recurrent calcium oxalate kidney stones in certain adults. The I...
  • No. Flares can happen early as uric acid shifts, and it can take months to settle. Your doctor will likely suggest colchicine or an anti-inflammatory to help prevent them. Keep tak...
  • I got a gout flare after starting it. Should I stop?
  • Nausea, diarrhea and mild changes in liver tests are the most common. A skin rash is the one to take seriously. Stop the medicine and get medical help right away if a rash or aller...
📖 Read our full Allopurinol guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.032 $3.17 / 100 tablets
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2021 Jul 2022 Dec 2025 Aug 2026 $0.059 $0.032
▼ Down 44% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
00591-5543-01 You're viewing this 100 TABLET in 1 BOTTLE, PLASTIC $0.0317 / ea $3.17 2009-04-06 — Discontinued by firm
00591-5543-10 0591-5543-10 Main listing 1000 TABLET in 1 BOTTLE, PLASTIC $0.0315 / ea $31.54 2009-04-06 — Active
00591-5543-00 0591-5543-00 31700 TABLET in 1 BAG — — — — Active
00591-5543-77 0591-5543-77 38088 TABLET in 1 CONTAINER — — — — Active

You're viewing the smallest of 4 pack sizes for this product.

This pack accounts for about 42% of this product's recent Medicaid fills; most go to the 1000 tablets pack. See all packs ↓

Pack size FAQ

What quantity is in this package?
This is a 100-count package — 100 tablet in 1 bottle, plastic.
How does this package differ from NDC 00591-5543-10?
Both are Allopurinol 100 mg Tablet — the drug itself is identical. This page's package is the 100-count one, while NDC 00591-5543-10 is the 1000 tablets package. Per-ea NADAC also differs: $0.0317 here vs $0.0315 for the 1000 tablets pack.
What NDC number is used to bill for this package of Allopurinol 100 mg Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Allopurinol 100 mg 00378-0137-01 Mylan 100 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mg 00603-2115-21 Par 100 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mg 00904-7041-61 Major 100 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mg 16571-0883-09 Rising 90 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mg 16714-0576-01 NorthStar 30 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mg 23155-0693-01 Heritage 100 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mg 29300-0349-01 Unichem 100 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mg 31722-0252-01 Camber 100 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mg 51079-0205-20 Mylan 100 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mg 53489-0156-01 Sun 100 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mg 55111-0729-01 Dr. 100 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mg 59651-0285-01 Aurobindo 100 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mg 60687-0677-01 American 100 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mg 62135-0516-31 Chartwell 300 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mg 69315-0291-01 Leading 100 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mg 70710-1209-00 Zydus 1000 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mg 71921-0240-01 Florida 100 tablets $0.032 AB Availability likely save 1%
Allopurinol 100 mgthis 00591-5543-01 Actavis 100 tablets $0.032 — Discontinued —
Allopurinol 100 mg 16729-0134-01 Accord 100 tablets $0.033 AB Availability likely +5%
Allopurinol 100 mg 00615-8385-05 NCS 15 tablets — AB FDA listed —
Allopurinol 100 mg 14445-0170-00 Indoco 1000 tablets — AB FDA listed —
Allopurinol 100 mg 43063-0935-01 PD-Rx 100 tablets — AB FDA listed —
Allopurinol 100 mg 43063-0975-20 PD-Rx 20 tablets — AB FDA listed —
Allopurinol 100 mg 48433-0002-20 Safecor 100 tablets — AB FDA listed —
Allopurinol 100 mg 50090-4662-03 A-S 30 tablets — AB FDA listed —
Allopurinol 100 mg 50090-5168-03 A-S 30 tablets — AB FDA listed —
Allopurinol 100 mg 50090-6715-03 A-S 30 tablets — AB FDA listed —
Allopurinol 100 mg 50090-6716-00 A-S 90 tablets — AB FDA listed —
Allopurinol 100 mg 50090-7696-03 A-S 30 tablets — AB FDA listed —
Allopurinol 100 mg 50090-7697-00 A-S 90 tablets — AB FDA listed —
Allopurinol 100 mg 50090-7791-00 A-S 100 tablets — AB FDA listed —
Allopurinol 100 mg 50090-7832-00 A-S 100 tablets — AB FDA listed —
Allopurinol 100 mg 50090-7833-00 A-S 90 tablets — AB FDA listed —
Allopurinol 100 mg 51655-0082-52 Northwind 30 tablets — AB FDA listed —
Allopurinol 100 mg 51655-0523-52 Northwind 30 tablets — AB FDA listed —
Allopurinol 100 mg 51655-0546-26 Northwind 90 tablets — — FDA listed —
Allopurinol 100 mg 51655-0945-52 Northwind 30 tablets — AB FDA listed —
Allopurinol 100 mg 55154-2338-00 Cardinal 10 tablets — AB FDA listed —
Allopurinol 100 mg 55154-5534-00 Cardinal 10 tablets — AB FDA listed —
Allopurinol 100 mg 60760-0656-90 St. 90 tablets — AB FDA listed —
Allopurinol 100 mg 60760-0710-90 ST. 90 tablets — AB FDA listed —
Allopurinol 100 mg 63187-0463-30 Proficient 30 tablets — AB FDA listed —
Allopurinol 100 mg 63629-2111-01 Bryant 1000 tablets — AB FDA listed —
Allopurinol 100 mg 66267-0665-30 NuCare 30 tablets — AB FDA listed —
Allopurinol 100 mg 67296-1897-03 Redpharm 30 tablets — AB FDA listed —
Allopurinol 100 mg 67544-0736-60 Aphena 90 tablets — AB FDA listed —
Allopurinol 100 mg 68071-2997-03 NuCare 30 tablets — AB FDA listed —
Allopurinol 100 mg 68071-3803-03 NuCare 30 tablets — AB FDA listed —
Allopurinol 100 mg 68071-3871-01 NuCare 100 tablets — AB FDA listed —
Allopurinol 100 mg 68788-4027-01 Preferred 100 tablets — AB FDA listed —
Allopurinol 100 mg 68788-8337-01 Preferred 100 tablets — AB FDA listed —
Allopurinol 100 mg 68788-8458-01 Preferred 100 tablets — AB FDA listed —
Allopurinol 100 mg 68788-8727-01 Preferred 100 tablets — AB FDA listed —
Allopurinol 100 mg 70518-3660-00 REMEDYREPACK 30 tablets — AB FDA listed —
Allopurinol 100 mg 70518-4062-01 REMEDYREPACK 90 tablets — AB FDA listed —
Allopurinol 100 mg 70518-4412-00 REMEDYREPACK 30 tablets — AB FDA listed —
Allopurinol 100 mg 70771-1126-00 Zydus 1000 tablets — AB FDA listed —
Allopurinol 100 mg 71205-0208-30 Proficient 30 tablets — AB FDA listed —
Allopurinol 100 mg 71335-0467-01 Bryant 100 tablets — AB Discontinued —
Allopurinol 100 mg 71335-1656-01 Bryant 100 tablets — — FDA listed —
Allopurinol 100 mg 71335-2347-01 Bryant 100 tablets — AB FDA listed —
Allopurinol 100 mg 71335-2416-01 Bryant 100 tablets — AB FDA listed —
Allopurinol 100 mg 71335-2542-01 Bryant 100 tablets — AB FDA listed —
Allopurinol 100 mg 71335-2744-01 Bryant 100 tablets — AB FDA listed —
Allopurinol 100 mg 71335-2775-01 Bryant 100 tablets — AB FDA listed —
Allopurinol 100 mg 71335-9641-01 Bryant 100 tablets — AB FDA listed —
Allopurinol 100 mg 71610-0194-30 Aphena 30 tablets — — FDA listed —
Allopurinol 100 mg 71610-0197-60 Aphena 90 tablets — AB FDA listed —
Allopurinol 100 mg 71610-0676-53 Aphena 60 tablets — AB FDA listed —
Allopurinol 100 mg 71610-0678-30 Aphena 30 tablets — AB FDA listed —
Allopurinol 100 mg 71610-0949-60 Aphena 90 tablets — AB FDA listed —
Allopurinol 100 mg 72162-1149-00 Bryant 1000 tablets — AB FDA listed —
Allopurinol 100 mg 72189-0437-90 Direct_Rx 90 tablets — AB FDA listed —
Allopurinol 100 mg 72865-0303-01 XLCare 100 tablets — AB FDA listed —
Allopurinol 100 mg 82638-0112-01 Harman 30 tablets — AB FDA listed —
Allopurinol 100 mg 53401-0019-60 Aphena 90 tablets — AB FDA listed —
Allopurinol 100 mg 72789-0596-90 PD-Rx 90 tablets — AB FDA listed —
Allopurinol 100 mg 85766-0287-01 Sportpharm 100 tablets — AB FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2009
On the market since
Apr 2009
📍
2026
Currently FDA-listed
17 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Allopurinol inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerActavis Pharma, Inc.
Labeler code00591
First marketedApr 2009
Product typeDrug For Further Processing
Portfolio324 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full FDA label FDA SPL

The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
1000 tablets00591-5543-10 1,693 Rx · $15,487
31700 tablets00591-5543-00 No Medicaid data
38088 tablets00591-5543-77 No Medicaid data
Drug total (last 4 qtrs): 2,924 Rx · 132,767 units · $26,871 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Allopurinol (matched by generic name) — the program that covers self-administered drugs. 19 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Allopurinol. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$25.19M
Claims incl. refills
2.4M
Beneficiaries
1.9M
Spend / beneficiary
$13.47
Spend / claim
$10.36
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Listed for further processing / repackaging No longer marketed (per FDA listing data)

What "drug for further processing" means

FDA lists this package under the "drug for further processing" marketing category: Actavis Pharma, Inc. supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Drug For Further Processing". Products approved under an application carry an NDA, ANDA, or BLA number.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 1000 tablets (00591-5543-10), 31700 tablets (00591-5543-00), 38088 tablets (00591-5543-77). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Actavis Pharma, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.